This human iPSC-derived trabecular meshwork model recapitulates key pathological features of glaucoma, including extracellular matrix remodelling, altered cytoskeletal organisation, contractility changes, and inflammatory stress.
Disease-like phenotypes are induced using clinically relevant triggers such as TGF-β2 or dexamethasone.
The model supports efficacy screening, target validation, and mechanism-of-action studies relevant to intraocular pressure regulation.
Retinal Ganglion Cell (RGC) Neurodegeneration Model
A human iPSC-derived retinal ganglion cell model used to study glaucoma-associated neurodegeneration.
Oxidative and metabolic stressors induce RGC injury, enabling assessment of neuroprotective strategies.
Readouts include cell survival, apoptosis, neurite integrity, and mitochondrial stress, supporting both prevention and rescue study designs.
Stargardt Disease (STGD1) Model
This model uses patient-derived or gene-edited iPSC-derived retinal pigment epithelium (RPE) to reproduce ABCA4-related pathology.
Under oxidative stress, cells accumulate lipofuscin and autofluorescent bisretinoids, leading to complement activation, barrier dysfunction, and cell death.
It is well suited for therapeutic screening and mechanistic studies.
Retinitis Pigmentosa (RP) Model
Closely related to the Stargardt platform, this iPSC-RPE-based disease model captures progressive retinal degeneration mechanisms, including impaired phagocytosis, oxidative stress sensitivity, and barrier breakdown.
It supports long-term culture to monitor disease progression and rescue effects.
Dry and Wet AMD RPE Stress Model
A human RPE-based model (ARPE-19 or iPSC-RPE) that mimics AMD pathology through A2E loading and photo-oxidative stress.
This induces mitochondrial dysfunction, ROS generation, inflammatory signalling, complement activation, and barrier impairment.
The model supports prevention and rescue paradigms relevant to both dry and wet AMD.
Immunology-Enhanced AMD Co-culture Model
An advanced RPE–immune cell co-culture system incorporating macrophages (M1/M2) or monocyte-derived cells to capture the contribution of innate immunity to AMD progression.
This premium model enables evaluation of immunomodulatory therapies and inflammatory drivers of retinal degeneration.
In Vitro Angiogenesis (Matrigel Tube Formation) Model
A high-throughput human endothelial cell assay used to screen compounds for anti-angiogenic or pro-angiogenic activity.
Key readouts include total tube length and network complexity, making it suitable for early screening of large compound sets.
Endothelial Co-culture Angiogenesis Model
A more physiologically relevant co-culture angiogenesis assay using two human cell types to assess functional angiogenic responses.
This model supports dose–response testing and is particularly relevant for retinal vascular diseases.